The 'Two Cultures' Have Endured

When I was 20 I had an English literature professor who insisted on the virtues of one's keeping a literary log—a chronicle of all the books read over the course of the year. All great men and women of letters did this, he said. In fact, it appeared that journal keeping was something of a prerequisite for being a man or woman of letters. With the enthusiasm and single-mindedness that often propel us (arid render us insufferable) when we're 20, I began such a project. At the end of two mont

Written byGregory Byrne
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

With the enthusiasm and single-mindedness that often propel us (arid render us insufferable) when we're 20, I began such a project. At the end of two months, I looked back over my entries in despair. There were at least as many Agatha Christies as there were Faulkners or Dos Passos. And when I cast my mind back to try to remember particulars of each book without referring to the brief annotations I had made, I found I could more often remember whodunit than exactly what stately, plump Buck Mulligan was doing coming down those stairs.

My literary sins had caught up with me. All my purchases at the campus bookstore (a copy of Murder at the Vicarage coyly peeking from under Absalom, Absalom) had been faithfully recorded to my shame. The project ended in disgrace.

Glashow refused to cooperate with the project, and in doing so, turned in one of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies